Priorities and strategy for the implementation of enhanced recovery after surgery (ERAS) in thoracic surgery
Highlight box
Key findings
• Compliance rates vary widely between the different recommendations of the enhanced recovery after surgery (ERAS) protocol in thoracic surgery.
• Patient-dependent measures that require active participation achieve the lowest compliance rate.
What is known and what is new?
• Compliance to ERAS recommendations remains a highly relevant success factor.
• ERAS recommendations should be divided into three groups, depending on the actors and their competencies.
What is the implication, and what should change now?
• This grouping enables a step-by-step gradual implementation and strengthening the long-time sustainability of ERAS in thoracic surgery.
• The process of implementation and sustainability needs to be further investigated.
Introduction
Over the last few decades, minimally invasive surgical techniques have become the standard procedure for lung cancer surgical management (1,2). Nevertheless, lung resections are still associated with perioperative morbidity and mortality regardless of the approach (3). Parallel to technical progress, it has therefore become necessary to pay increasing attention to perioperative complications and their management, initially to reduce length of stay (LOS) and complication rates and nowadays also to enable patients to participate in multimodal therapy concepts (4). Every operation is associated with certain level of stress reaction to the human body, which can potentially be reduced (5). Enhanced recovery after surgery (ERAS®) offers such perioperative care elements, which aim to identify general and individual stress factors, counteract them in a targeted manner and maintain physiological functions (6).
The ERAS® protocol has been introduced worldwide in various modifications since the publication of the European Society of Thoracic Surgery (ESTS)/ERAS guidelines in 2019. The increasing number of publications dealing with ERAS® confirmed the importance of this topic (7). The 45 recommendations cover the preoperative, intraoperative and postoperative care (8). The recommendations are evidence-based and the strength of each recommendation takes into account the desired outcome. However, the exact pathophysiological way in which the 45 recommendations and their synergisms contribute to improving recovery and reducing complications is not yet fully understood (9).
ERAS® is not a task for surgeons alone, but rather a multimodal clinical concept carried out by a multidisciplinary team of physicians, nursing staff and organizational personnel (10). In this way, ERAS® has the opportunity to fulfil the so-called “Quadruple Aim” in healthcare, which is firstly to achieve better outcomes for patients, secondly to reduce costs, thirdly to improve the experience of patients, doctors and nursing staff and fourthly to increase the satisfaction of healthcare providers (11).
The success of ERAS® essentially depends on the implementation level and compliance with the protocol (12,13). The implementation process was not sufficiently studied yet and that there is a lot of potential that should be exploited. The focus of the discussion should be on the best possible overall recovery from surgery rather than on surgical details (14).
Primary objective of the study was to evaluate the implementation of ERAS®-based recommendations, but slightly modified enhanced recovery after thoracic surgery (ERATS) protocol for elective lung resections and to identify the compliance of specific, clinically relevant variables of our protocol. We present this article in accordance with the STROBE reporting checklist (available at https://jtd.amegroups.com/article/view/10.21037/jtd-23-1866/rc).
Methods
Study design
In this prospective, observational study a total of 152 patients with an indication for lung resection at the Department of Thoracic Surgery (University Hospital Regensburg, Germany) were screened between July 2021 and June 2022. Inclusion criteria were age >18 years and an elective admission. Patients with severe preoperative immobility or language barrier were excluded. Finally, 139 patients were identified and entered into an electronic database. Data collection included patient demographics, general and surgical factors as well as compliance with each element of the ERATS protocol guidelines. The study was conducted in accordance with the Declaration of Helsinki (as revised in 2013). The study was approved by the ethics committee of the University of Regensburg (No. 23-3216-104). Individual patient consent was waived because of routine patient care and the retrospective analysis’s nature.
ERATS protocol
In the initial analysis, center-specific, protocol-compliant ERATS elements were identified. Individual recommendations from all three phases (preoperative, intraoperative and postoperative) were already established. Furthermore, new measures were initiated to establish a workflow according to the ERATS protocol guidelines (Table 1). A broad interdisciplinary consensus was reached in a multidisciplinary team (surgery, anesthesiology, nursing staff, physiotherapy, etc.) involved in the treatment. ERATS-specific information for patients was newly introduced.
Table 1
Phase | Recommendation |
---|---|
Preoperative | Education/counselling ERATS conform |
Pulmonary prehabilitation | |
Smoking cessation | |
Oral carbohydrate loading | |
Anemia management | |
Intraoperative | Perioperative anesthesiology related items |
Perioperative antibiotics | |
Intraoperative warming | |
Regional/multimodal anesthesia | |
Minimally invasive surgery | |
Antero-lateral thoracotomy | |
Postoperative | Postoperative admission to standard surgical ward |
Chest drain management | |
Catheter management | |
Early mobilization |
ERATS, enhanced recovery after thoracic surgery.
An internal audit of the current therapy standards was initially carried out, which confirmed, that several recommendations of the ERAS®-guideline were already addressed as part of the department’s internal therapy standards (8). These included anesthesiology-related items (Table 2), the chest drain management (Table 3) and some general perioperative procedures such as perioperative antibiotics, surgical field preparation and anemia management.
Table 2
No routine preoperative administration of sedatives |
Lung-protective strategies during one-lung ventilation |
Short acting analgesics |
Normovolemic fluid regime and use of vasopressors |
PONV control |
PONV, postoperative nausea and vomiting.
Table 3
Use of single chest tube |
Chest tube diameter 20–24 Charrière |
No aspiration therapy by wedge-resection or standard lobar resection without air leakage |
Chest X-ray on 1st POD |
Chest drain removal if no air leakage and drain flow <450 mL/24 h |
Chest drain removal by absence of hemorrhagic/chyle secretion |
Chest drain removal by absence of clinically relevant pneumothorax |
Use of digital drain system if chest tube cannot be removed on 1st POD |
POD, postoperative day.
As part of the modified ERATS protocol, patients received informal preoperative ERAS® education/counselling through medical staff at least a day before operation. Pulmonary exercise with breathing trainer (Volumetric Exerciser VS 5000, Medtronic, Germany) and inhaled mucolytic was initiated preoperatively. Instructions were given by both medical and nursing staff one to three days before surgery. Preoperative carbohydrate loading was newly introduced (200 mL Fresubin® 2kCal, Fresenius Medical Care, Germany). Smoking cessation was not addressed in a particular matter as there are publicly accessible subliminal offers for smoking cessation in our hospital. Nutritional assessment is one of the standard procedures regularly carried out by nursing staff and was therefore not included as a specific point in our protocol. Venous thromboembolism (VTE) prophylaxis was excluded from the analysis as it was addressed in the national guidelines similar to ERAS® recommendations.
Particular attention was paid to multimodal pain therapy with a focus on regional analgesia. Thoracic epidural analgesia (TEA) was not used routinely, but only in planned thoracotomies, while erector spine plane block (ESPB) and local analgesia were mainly used for VATS. Strong oral opioid medication was subsequently reduced after removing the chest tube and was slowly phased out under daily pain monitoring and outpatient conditions. Central venous catheter was not placed routinely. Urinary catheter would be inserted if the operative time was expected to be more than 3 hours.
Nursing staff were made aware of the need for early mobilization of patients. Physiotherapy was carried out daily to encourage the mobilization. Initial mobilization in a sitting position took place on the day of surgery and out of bed, going to toilette and walking along the corridor on 1st POD. All patients were reviewed daily, including weekends, by an attending thoracic surgeon.
Study endpoints
The primary endpoint concerned the implementation and compliance with the modified ERATS protocol. Secondary endpoints concerned specific and clinically relevant recommendations regarding their clinical application and impact on compliance.
Statistical analysis
A retrospective analysis of prospectively collected data was performed. Descriptive methods were used to analyze the data. Total numbers, frequencies and mean values were described. Parameters were specified in absolute or relative frequency if applicable with standard deviation. The statistical analysis with graphical representation of the results was carried out with Microsoft Excel (version 2108).
Results
Patient demographics
Table 4 shows an overview of the study sample with most relevant treatment data. A total of 112 patients (81%) received complete preoperative workup as outpatients, while the remaining patients were hospitalized for missing diagnostic examinations, which led to consecutive extension of the LOS. In addition to the lack of diagnostics, capacity restrictions during coronavirus disease 2019 (COVID-19) pandemic were also among the reasons for postponements. Our standard of care included a planned stay in the intensive care unit (ICU) for patients undergoing sleeve-resection (4%) or pneumonectomy (3%). Furthermore, the ICU was reserved for patients with relevant concomitant comorbidities such as renal insufficiency requiring dialysis. Among the most common unscheduled reasons for postoperative admission to the ICU was failed weaning from catecholaminergic medication (9%) followed by temporary respiratory insufficiency (7%). The median length of postoperative hospital stay was 7 days (range, 1–57 days). The overall perioperative complication rate was 19%. No patient died within the first 30 days postoperatively.
Table 4
Variable | Values (n=139) |
---|---|
Age, years | 64±11 |
Gender, female | 57 [41] |
Physical status | |
ASA I | 2 [1] |
ASA II | 40 [29] |
ASA III | 94 [68] |
ASA IV | 3 [2] |
ICU postoperative | 54 [39] |
Hospital stay, days | 8.5±6.3 |
Data are presented as mean ± standard deviation or n [%]. SD, standard deviation; ASA, American Society of Anesthesiologists; ICU, intensive care unit.
Treatment data
Table 5 shows an overview of surgical and regional anesthetic procedures. Simultaneous lymphadenectomy was performed in 93 patients (67%). Regional analgesia was also used in combination as part of the multimodal therapy concept. There were no complications in association with regional analgesia at all.
Table 5
Variable | Values (n=139) |
---|---|
Surgical approach, n [%] | |
Minimal-invasive surgery (VATS) | 100 [72] |
Antero-lateral, muscle-sparing thoracotomy | 37 [27] |
NI-VATS | 2 [1] |
Type of surgical lung resection, n [%] | |
Sublobar resection, including segmentectomy | 86 [62] |
Lobectomy | 49 [35] |
Pneumonectomy | 4 [3] |
Regional anesthesia (multiple counts possible), n [%] | |
ESPB | 96 [69] |
TEA | 31 [22] |
Intercostal pain catheter (PainBuster®) | 31 [22] |
Local infiltration analgesia | 27 [19] |
VATS, video-assisted thoracic surgery; NI-VATS, non-intubated video-assisted thoracic surgery; ESPB, erector spinae plane block; TEA, thoracic epidural analgesia.
Compliance to ERATS
The center-specific ERATS-compliant recommendations which were already established prior to the beginning of the study were given a baseline score of 100%, whereas the measures newly introduced in accordance with the ERATS protocol were assigned 0% in the preliminary analysis (Figure 1). The measured compliance was highly variable across individual parameters.
The recommendations that were already part of standard therapy achieved the best compliance rates. These included perioperative antibiotics (compliance 100%), intraoperative warming (98%) and in case of open surgical techniques antero-lateral thoracotomy (100%). Some of the recommendations were expected to achieve high compliance rate as they were individual measures, such as preoperative education/counseling (80%), carbohydrate loading (69%) and anemia management (95%). The recommendations for one-lung ventilation and other anesthesiologic aspects such as normovolemia were also successfully implemented (compliance 96%). We have noticed that there were considerable deficits in the handling of chest drains (Table 6) and catheter management (central venous catheter 55%; urinary catheter 60%). Most difficulties were encountered in the management of patient-dependent measures such as smoking cessation (10%), pulmonary exercise (58%) and early mobilization. We identified different rates of compliance with the ERATS protocol depending on three groups (Figure 2): (I) patient-depending measures which require active participation (49.3%); (II) treatment measures requiring interdisciplinary consensus (85.8%); (III) surgical measures (88%).
Table 6
Variable | Values (n=139) |
---|---|
Single chest drain used | 123 [88] |
Size of chest tube | |
20 Charrière | 18 [13] |
24 Charrière | 120 [86] |
26 Charrière | 1 [1] |
Duration of chest tube drainage, days | 3.0±2.5 |
Digital drainage system used | 75 [54] |
Data are presented as mean ± standard deviation or n [%].
Discussion
The implementation of ERAS® recommendations in thoracic surgery still represents a challenge, as not only clinical procedures, but often also administrative issues need to be addressed, which requires a multidisciplinary team approach (15). In addition, it can be assumed that the increasing demand for ERAS® will come from the patients themselves in the near future. Patients will change from a passive recipient of (health-) care to an active player. In this context, we are observing a shift towards greater patient involvement in shared-decision making process regarding treatment plans as known from lung cancer screening programs (16,17). Our clinical practice had already shown that adherence to different ERATS measures varied greatly. Adherence to the measures that require active patient participation requires a great deal of effort. Therefore, the benefits of active participation in the treatment process must be explained to patients in a simple and understandable way. This can increase patient motivation and thus also compliance to protocol guidelines (18).
Our data proved, that the compliance with the ERATS protocol varied significantly in all three phases of the perioperative process. Taking into account the clinical implementation, we recommend categorization into the following three newly defined groups:
- Patient-depending measures which require active participation;
- Treatment measures requiring interdisciplinary consensus;
- Surgical measures.
In addition to traditional classification into preoperative, intraoperative and postoperative elements, new grouping seems to facilitate the implementation of an ERATS program. It could help in cases where, for example, no consensus has yet been reached between all healthcare providers.
- Group 1—patient-depending measures that require active participation—had the lowest overall compliance of only 49% with our ERATS protocol. Smoking cessation and pulmonary exercise require active patient participation and strong motivation. They also require a change in patient lifestyle and habits. This must be addressed on an individual basis and additional easily accessible advice centers should be created. Since the overall compliance rate in this group was insufficient, special attention should be paid to this group. It can be argued that a high level of compliance in this group has a positive effect on quality of life, which could become by far the most important parameter in the future (19-21).
- Group 2—treatment measures requiring interdisciplinary consensus—contains recommendations that can be implemented with satisfactory compliance of 86% once a consensus has been reached within the entire treatment team because they are usually single item recommendations with a relatively easy accomplishment. These include general perioperative elements independent of surgical subspecialty (e.g., anemia management, prophylactic antibiotics, intraoperative warming) as well as anesthesia-related recommendations which are of general applicability (e.g., short acting anesthetics, normovolemic fluid regime and use of vasopressors, PONV control) and lung-protective strategies during one-lung ventilation used specifically in thoracic surgery (22). Same day surgery for example, could have a significant impact on LOS, which has become a frequently assessed parameter concerning ERAS® although its relevance might be marginal regarding to patient outcome (23). Urinary catheters and invasive monitoring instruments severely restrict patient mobility. Particular attention should be paid to the early removal of these measures in order to increase compliance with regard to mobilization.
- Group 3—surgical measures—are characterized by the fact that the entire management is in the hands of the surgical team and showed an excellent compliance rate of 88%. On the other hand, problems may arise as to which compromises are accepted, e.g., with chest drain management. This is certainly based on regional practices. While in some regions discharge with the chest drain attached to a one-way valve is accepted in case of persistent air leakage, in other regions this would probably lead to postponement of discharge (24,25). In addition, the willingness of the surgical staff to replace traditional procedures with evidence-based approach could vary greatly. In particular, a quality review meeting showed a significantly improved compliance to elements of the thoracic ERAS® protocol and should therefore be considered for implementing surgical protocols (26).
Most of the ERAS® recommendations are not new, suggesting improved recovery by strengthening the synergistic effects of all measures (13). The premise under which complications after surgical interventions were considered have changed. Therefore, perioperative management must also be reconsidered. Without appropriate measures, there is a risk that some patients will not participate in multimodal therapy.
Limitations and perspectives
We are aware of the limitations of this study in terms of sample size and single center implementation. In addition, a rather heterogeneous sample of surgical procedures was studied, including both cancer and benign diagnoses, which could potentially play an important role with regard to psychosomatic aspects. The next problem we see is the lack of possibility to compare the ERATS group with a control group. There is a considerable contamination between the two hypothetical groups because some recommendations were usually already implemented in the control group. Another critical aspect regarding compliance is the relative shortage of personnel due to high workload for already existing staff. This point becomes particularly important when new procedures are introduced. This became particularly clear during the Covid pandemic, which led to a shortage of medical staff and operating room capacity. The outcome of early mobilization could not be evaluated in our study due to lack of standardization and institutional changes, nevertheless the same issue discussed above applies to this element. On the other hand, increasing standardization and greater familiarity with the protocol leads to better convalescence and earlier discharge of patients, which should relieve nursing staff in the future. Digital-based applications are also conceivable here.
Conclusions
In conclusion, the ERAS® guideline for lung resections are very wide-reaching. Compliance to these perioperative care recommendations remains a highly relevant success factor. The implementation and continuous evaluation of our perioperative ERATS protocol led to a new categorization into three groups. This additional categorization might help to quickly identify the weak points in the implementation process and can hopefully contribute to a higher compliance of ERATS through a focused approach.
Acknowledgments
Funding: None.
Footnote
Reporting Checklist: The authors have completed the STROBE reporting checklist. Available at https://jtd.amegroups.com/article/view/10.21037/jtd-23-1866/rc
Data Sharing Statement: Available at https://jtd.amegroups.com/article/view/10.21037/jtd-23-1866/dss
Peer Review File: Available at https://jtd.amegroups.com/article/view/10.21037/jtd-23-1866/prf
Conflicts of Interest: All authors have completed the ICMJE uniform disclosure form (available at https://jtd.amegroups.com/article/view/10.21037/jtd-23-1866/coif). The authors have no conflicts of interest to declare.
Ethical Statement: The authors are accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved. The study was conducted in accordance with the Declaration of Helsinki (as revised in 2013). The study was approved by the ethics committee of the University of Regensburg (No. 23-3216-104). Individual patient consent was waived because of routine patient care and the retrospective analysis’s nature.
Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0/.
References
- Bertolaccini L, Fornaro G, Ciani O, et al. The Impact of Surgical Experience in VATS Lobectomy on Conversion and Patient Quality of Life: Results from a Comprehensive National Video-Assisted Thoracic Surgical Database. Cancers (Basel) 2023;15:410. [Crossref] [PubMed]
- Sedighim S, Frank MI, Heutlinger O, et al. A Systematic Review of Short-Term Outcomes of Minimally Invasive Thoracoscopic Surgery for Lung Cancer after Neoadjuvant Systemic Therapy. Cancers (Basel) 2023;15:3908. [Crossref] [PubMed]
- Muñoz de Cabo C, Hermoso Alarza F, Cossio Rodriguez AM, et al. Perioperative management in thoracic surgery. Med Intensiva (Engl Ed) 2020;44:185-91. [Crossref] [PubMed]
- Schmid S, Minnella EM, Pilon Y, et al. Neoadjuvant Prehabilitation Therapy for Locally Advanced Non-Small-Cell Lung Cancer: Optimizing Outcomes Throughout the Trajectory of Care. Clin Lung Cancer 2022;23:593-9. [Crossref] [PubMed]
- Kehlet H. Multimodal approach to control postoperative pathophysiology and rehabilitation. Br J Anaesth 1997;78:606-17. [Crossref] [PubMed]
- Gillis C, Ljungqvist O, Carli F. Prehabilitation, enhanced recovery after surgery, or both? A narrative review. Br J Anaesth 2022;128:434-48. Erratum in: Br J Anaesth 2022;128:1061.
- Zhang W, Zhang Y, Qin Y, et al. Outcomes of enhanced recovery after surgery in lung cancer: A systematic review and meta-analysis. Asia Pac J Oncol Nurs 2022;9:100110. [Crossref] [PubMed]
- Batchelor TJP, Rasburn NJ, Abdelnour-Berchtold E, et al. Guidelines for enhanced recovery after lung surgery: recommendations of the Enhanced Recovery After Surgery (ERAS®) Society and the European Society of Thoracic Surgeons (ESTS). Eur J Cardiothorac Surg 2019;55:91-115. [Crossref] [PubMed]
- Comacchio GM, Monaci N, Verderi E, et al. Enhanced recovery after elective surgery for lung cancer patients: analysis of current pathways and perspectives. J Thorac Dis 2019;11:S515-22. [Crossref] [PubMed]
- Joliat GR, Ljungqvist O, Wasylak T, et al. Beyond surgery: clinical and economic impact of Enhanced Recovery After Surgery programs. BMC Health Serv Res 2018;18:1008. [Crossref] [PubMed]
- Sikka R, Morath JM, Leape L. The Quadruple Aim: care, health, cost and meaning in work. BMJ Qual Saf 2015;24:608-10. [Crossref] [PubMed]
- Forster C, Gonzalez M. Enhanced recovery after surgery (ERAS): philosophy, theory and practice. J Thorac Dis 2022;14:3684-7. [Crossref] [PubMed]
- Rogers LJ, Bleetman D, Messenger DE, et al. The impact of enhanced recovery after surgery (ERAS) protocol compliance on morbidity from resection for primary lung cancer. J Thorac Cardiovasc Surg 2018;155:1843-52. [Crossref] [PubMed]
- Sihoe ADL. ERAS versus EGO. J Thorac Dis 2018;10:S1242. [Crossref] [PubMed]
- Dyas AR, Kelleher AD, Erickson CJ, et al. Development of a universal thoracic enhanced recover after surgery protocol for implementation across a diverse multi-hospital health system. J Thorac Dis 2022;14:2855-63. [Crossref] [PubMed]
- Tanner NT, Silvestri GA. Shared Decision-making and Lung Cancer Screening: Let's Get the Conversation Started. Chest 2019;155:21-4. [Crossref] [PubMed]
- Walsh JME, Karliner L, Smith A, et al. LungCARE: Encouraging Shared Decision-Making in Lung Cancer Screening-a Randomized Trial. J Gen Intern Med 2023;38:3115-22. [Crossref] [PubMed]
- Petersen RH, Huang L, Kehlet H. Guidelines for enhanced recovery after lung surgery: need for re-analysis. Eur J Cardiothorac Surg 2021;59:291-2. [Crossref] [PubMed]
- Abidi Y, Fekete M, Farkas Á, et al. Effectiveness and quality of life in lung cancer, pre-, post- and perioperative rehabilitation - A review. Physiol Int 2023;110:89-107. [Crossref] [PubMed]
- Voorn MJJ, Driessen EJM, Reinders RJEF, et al. Effects of exercise prehabilitation and/or rehabilitation on health-related quality of life and fatigue in patients with non-small cell lung cancer undergoing surgery: A systematic review. Eur J Surg Oncol 2023;49:106909. [Crossref] [PubMed]
- Halms T, Strasser M, Hasan A, et al. Smoking and quality of life in lung cancer patients: systematic review. BMJ Support Palliat Care 2024;13:e686-94. [Crossref] [PubMed]
- Bernasconi F, Piccioni F. One-lung ventilation for thoracic surgery: current perspectives. Tumori 2017;103:495-503. [Crossref] [PubMed]
- Smith TW Jr, Wang X, Singer MA, et al. Enhanced recovery after surgery: A clinical review of implementation across multiple surgical subspecialties. Am J Surg 2020;219:530-4. [Crossref] [PubMed]
- Cerfolio RJ, Bass CS, Pask AH, et al. Predictors and treatment of persistent air leaks. Ann Thorac Surg 2002;73:1727-30; discussion 1730-1. [Crossref] [PubMed]
- Rice TW, Okereke IC, Blackstone EH. Persistent air-leak following pulmonary resection. Chest Surg Clin N Am 2002;12:529-39. [Crossref] [PubMed]
- Dyas AR, Kelleher AD, Cumbler EU, et al. Quality Review Committee Audit Improves Thoracic Enhanced Recovery After Surgery Protocol Compliance. J Surg Res 2024;293:144-51. [Crossref] [PubMed]